J. Safra Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.26K Hold
2025
Q1
$1.89K Hold
2024
Q4
$1.65K Hold
2024
Q3
$1.92K Buy
2023
Q4
Sell
2023
Q3
$354 Hold
2023
Q2
$380 Hold
2023
Q1
$400 Hold
2022
Q4
$0 Buy